» Articles » PMID: 32257040

Phosphaturic Mesenchymal Tumors from Head to Toe: Imaging Findings and Role of the Radiologist in Diagnosing Tumor-Induced Osteomalacia

Overview
Journal Indian J Orthop
Publisher Springer Nature
Specialty Orthopedics
Date 2020 Apr 8
PMID 32257040
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed at evaluating the imaging findings of phosphaturic mesenchymal tumors and tumor-induced osteomalacia and assess the clinical and biochemical profiles of patients with tumor-induced osteomalacia.

Materials And Methods: Imaging findings in six patients with tumor-induced osteomalacia and histopathologically proven phosphaturic mesenchymal tumors were evaluated. Clinical and biochemical profiles of these patients were also assessed.

Results: Along with having a characteristic biochemical profile, patients with phosphaturic mesenchymal tumors also have certain imaging findings which can aid in the diagnosis such as increased uptake on DOTA PET-CT and homogeneous post-contrast enhancement on CT and MRI.

Conclusion: Patients with tumor-induced osteomalacia have characteristic symptoms, imaging and biochemical profiles. For radiologists, raising the suspicion of a phosphaturic mesenchymal tumor in patients with refractory hypophosphatemic osteomalacia as well as localizing the tumor on imaging is crucial, as complete excision of the tumor leads to resolution of the osteomalacia and the patient's clinical symptoms.

Citing Articles

PTH like substance secreting mesenchymal tumor causing oncogenic osteomalacia; unravelling the difficulties in localization - A report of 2 cases.

Jijulal C, Sreedharan S, Naveen P G, Surendran S, Patinharayil G, Fazil V V M J Orthop. 2024; 58:123-127.

PMID: 39114427 PMC: 11301177. DOI: 10.1016/j.jor.2024.06.034.


Phosphaturic mesenchymal tumor: two cases highlighting differences in clinical and radiologic presentation.

Gu J, Ge C, Joshi G, Most M, Tai R Skeletal Radiol. 2023; 53(5):995-1002.

PMID: 37792035 DOI: 10.1007/s00256-023-04462-w.


Tumor-induced osteomalacia characterized by "painful knee joint with difficulty in moving": a case report.

Jiang L, Tan Q, Gao C, Xu L, Zhu J, Yan P BMC Endocr Disord. 2022; 22(1):174.

PMID: 35804355 PMC: 9270841. DOI: 10.1186/s12902-022-01078-4.


Phosphaturic Mesenchymal Tumor.

Benson J, Trejo-Lopez J, Nassiri A, Eschbacher K, Link M, Driscoll C AJNR Am J Neuroradiol. 2022; 43(6):817-822.

PMID: 35589138 PMC: 9172954. DOI: 10.3174/ajnr.A7513.


Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway.

Hussein M, Cafarelli F, Paparella M, Rennie W, Guglielmi G Radiol Med. 2021; 126(12):1609-1618.

PMID: 34453276 PMC: 8702419. DOI: 10.1007/s11547-021-01412-1.


References
1.
Arnaoutakis D, Naseri I . Sinonasal Phosphaturic Mesenchymal Tumor: A Rare and Misinterpreted Entity. J Neurol Surg Rep. 2015; 76(2):e233-8. PMC: 4648724. DOI: 10.1055/s-0035-1562852. View

2.
Shustik D, Ng D, Sittampalam K . Phosphaturic mesenchymal tumour mixed connective tissue variant: report of three cases with unusual histological findings. Int J Clin Exp Pathol. 2015; 8(6):7506-17. PMC: 4525996. View

3.
Ghorbani-Aghbolaghi A, Darrow M, Wang T . Phosphaturic mesenchymal tumor (PMT): exceptionally rare disease, yet crucial not to miss. Autops Case Rep. 2017; 7(3):32-37. PMC: 5634432. DOI: 10.4322/acr.2017.031. View

4.
Gaasbeek A, Meinders A . Hypophosphatemia: an update on its etiology and treatment. Am J Med. 2005; 118(10):1094-101. DOI: 10.1016/j.amjmed.2005.02.014. View

5.
Qiu S, Cao L, Qiu Y, Yan P, Li Z, Du J . Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report. Medicine (Baltimore). 2017; 96(17):e6750. PMC: 5413265. DOI: 10.1097/MD.0000000000006750. View